BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23601370)

  • 1. LiverAtlas: a unique integrated knowledge database for systems-level research of liver and hepatic disease.
    Zhang Y; Yang C; Wang S; Chen T; Li M; Wang X; Li D; Wang K; Ma J; Wu S; Zhang X; Zhu Y; Wu J; He F
    Liver Int; 2013 Sep; 33(8):1239-48. PubMed ID: 23601370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systems biology-based classifier for hepatocellular carcinoma diagnosis.
    Zhang Y; Wang S; Li D; Zhnag J; Gu D; Zhu Y; He F
    PLoS One; 2011; 6(7):e22426. PubMed ID: 21829460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of multistage hepatocarcinogenesis.
    Sakamoto M; Effendi K; Masugi Y
    Jpn J Clin Oncol; 2010 Sep; 40(9):891-6. PubMed ID: 20603246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities for oncology biomarker discovery.
    Deyati A; Younesi E; Hofmann-Apitius M; Novac N
    Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCCNet: an integrated network database of hepatocellular carcinoma.
    He B; Qiu X; Li P; Wang L; Lv Q; Shi T
    Cell Res; 2010 Jun; 20(6):732-4. PubMed ID: 20479783
    [No Abstract]   [Full Text] [Related]  

  • 12. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.
    Su WH; Chao CC; Yeh SH; Chen DS; Chen PJ; Jou YS
    Nucleic Acids Res; 2007 Jan; 35(Database issue):D727-31. PubMed ID: 17098932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
    Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining literature text mining with microarray data: advances for system biology modeling.
    Faro A; Giordano D; Spampinato C
    Brief Bioinform; 2012 Jan; 13(1):61-82. PubMed ID: 21677032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYCLONET--an integrated database on cell cycle regulation and carcinogenesis.
    Kolpakov F; Poroikov V; Sharipov R; Kondrakhin Y; Zakharov A; Lagunin A; Milanesi L; Kel A
    Nucleic Acids Res; 2007 Jan; 35(Database issue):D550-6. PubMed ID: 17202170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.
    Grate LR
    BMC Bioinformatics; 2005 Apr; 6():97. PubMed ID: 15826317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hepatocellular carcinoma and metastatic hepatic carcinoma via functional modules in a protein-protein interaction network.
    Pan J; Cong Z; Zhong M; Sun Y
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C186-94. PubMed ID: 25450280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatment.
    Schmidt C; Marsh JW
    Curr Opin Organ Transplant; 2010 Jun; 15(3):277-82. PubMed ID: 20414113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems biology of human atherosclerosis.
    Shalhoub J; Sikkel MB; Davies KJ; Vorkas PA; Want EJ; Davies AH
    Vasc Endovascular Surg; 2014 Jan; 48(1):5-17. PubMed ID: 24212404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.